Nor-NOHA (monoacetate)
Nor-NOHA monoacetate is a selective and reversible arginase inhibitor. nor-NOHA monoacetate induces apoptosis in ARG2-expressing cells under hypoxia. nor-NOHA monoacetate has anti-leukemic activity. nor-NOHA monoacetate can used in study of endothelial dysfunction, immunosuppression and metabolism[1].
Product Specifications
CAS Number
2250019-93-1
Product Name Alternative
Nω-Hydroxy-nor-L-arginine (monoacetate)
UNSPSC
12352211
Target
Arginase
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/nor-noha-monoacetate.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)
Smiles
N[C@H](C(O)=O)CCNC(NO)=N.O=C(C)O
Molecular Formula
C7H16N4O5
Molecular Weight
236.23
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Citation 01
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL
P27 / KIP1 (KIP1/769), CF640R conjugate, 0.1mg/mL
CD43 (T-Cell Marker) (rSPN/1094), CF488A conjugate, 0.1mg/mL
Pgp9.5 (UCHL-1) (31A3), CF488A conjugate, 0.1mg/mL
